Machine Learning

With new CPO and CRO hires, Limble signals an aggressive push to scale its AI maintenance platform and cement its leadership in a competitive industry.

Gartner recognizes ETQ for its visionary QMS platform as the industry tackles supply chain risks and embraces data-driven, automated quality management.

A new feature sends a compliant text moments before an AI call, promising to boost connection rates, enhance revenue, and rebuild trust in sales outreach.

BlackSky's new deal validates its high-tech satellite intel, proving its model for turning trials into major contracts in the competitive space-tech market.

A major multi-vendor study confirms AI's power for precision HER2 scoring, promising to improve diagnostics and accelerate personalized cancer therapies.

Quanterix has submitted a multi-biomarker blood test to the FDA, a move that could revolutionize early Alzheimer's diagnosis and patient care.

AVerMedia launches its Live Streamer app for on-the-go production and adds AI-powered updates to its PC software, creating a unified creator ecosystem.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

Private equity giant AEA Investors acquires a majority stake in Magna5, signaling a major push to scale IT services for businesses under cyber siege.

As AI data centers strain power grids, a tiny new component from Microchip promises to boost power density and efficiency, fueling the next wave of computing.

A new partnership aims to slash waste and streamline clinical trials, heralding a tech-driven transformation in the backbone of drug development.

Catapult launches the portable Perch P2, a camera-based system using AI to track athlete performance anywhere, from the weight room to the field.

A breakthrough in cancer therapy as Avacta's faridoxorubicin proves so safe, regulators have removed historic dosing limits tied to heart toxicity.

Novo Nordisk exec Karin Conde-Knape joins Valo as CSO, signaling a major validation for AI's role in creating next-generation medicines.

A new report reveals a major shift in hospital spending, with tech and infrastructure costs now rising faster than drugs for the first time in a decade.

Powersports giant Massimo Group's stock plummets after announcing a bold but risky plan to acquire an AI firm and enter the health robotics market.

Thoughtworks hires Karthik Srinivasan to scale its AI/works™ platform, betting big on autonomous AI to reshape enterprise software and drive growth.

A next-gen immunotherapy enters trials, hoping its safer design can unlock the immune system and form a potent combo against advanced solid tumors.

The strategic buyout extends the DAP leader's reach beyond web apps, promising a universal, AI-powered solution for complex enterprise IT environments.

A new report finds developers use AI weekly for productivity, but a deep trust deficit remains due to inconsistent outputs, reshaping the role of human oversight.